0591-0617 : Ms 100 mg Extended Release Tablet

NDC:	0591-0617
Labeler:	Watson Laboratories, Inc.
Drug Name:	Morphine Sulfate
Rev. Date:	Apr 12, 2006
CSA Schedule:	CII (US) [1]

^[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:

Markings:	WATSON;617
Shapes:	Round
Colors:	Gray
Size (mm):	8
Segments: *	1
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Active Ingredients:

• Morphine

Inactive Ingredients:

• Cetostearyl Alcohol
• Hydroxyethyl Cellulose
• Hydroxypropyl Cellulose
• Hypromellose
• Magnesium Stearate
• Polyethylene Glycol
• Polysorbate 80
• Synthetic Black Iron Oxide
• Talc
• Titanium Dioxide

Related Products:

Based on records with the same trade name.

• 0591-3449 Ms 20 mg Extended Release Capsule by Watson Laboratories, Inc.
• 0591-3450 Ms 30 mg Extended Release Capsule by Watson Laboratories, Inc.
• 0591-3451 Ms 50 mg Extended Release Capsule by Watson Laboratories, Inc.
• 0591-3452 Ms 60 mg Extended Release Capsule by Watson Laboratories, Inc.
• 0591-3453 Ms 100 mg Extended Release Capsule by Watson Laboratories, Inc.
• 0591-3576 Ms 80 mg Extended Release Capsule by Watson Laboratories, Inc.
• 0591-3740 Ms 15 mg Extended Release Tablet by Watson Laboratories, Inc.
• 0591-3741 Ms 30 mg Extended Release Tablet by Watson Laboratories, Inc.
• 0591-3742 Ms 60 mg Extended Release Tablet by Watson Laboratories, Inc.
• 0591-3743 Ms 100 mg Extended Release Tablet by Watson Laboratories, Inc.
• 0591-3744 Ms 200 mg Extended Release Tablet by Watson Laboratories, Inc.
• 0054-0235 Ms 15 mg Oral Tablet by Roxane Laboratories, Inc
• 0054-0236 Ms 30 mg Oral Tablet by Roxane Laboratories, Inc
• 0054-0237 Morphine Sulfate 10 mg/5ml Oral Solution by Roxane Laboratories, Inc
• 0054-0238 Morphine Sulfate 20 mg/5ml Oral Solution by Roxane Laboratories, Inc
• 0054-0404 Morphine Sulfate 100 mg/5ml Oral Solution by Roxane Laboratories, Inc
• 0054-0517 Morphine Sulfate 100 mg/5ml Oral Solution by Roxane Laboratories, Inc
• 0115-1277 Morphine Sulfate 20 mg Oral Capsule, Extended Release by Impax Generics
• 0115-1278 Morphine Sulfate 30 mg Oral Capsule, Extended Release by Impax Generics
• 0115-1279 Morphine Sulfate 50 mg Oral Capsule, Extended Release by Impax Generics
• More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:



< Prev: 0591-0607Next: 0591-0657 >

Related Discussions: